Li-Xin Zhou Selected Research

human ERBB2 protein

4/2019

Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Xin Zhou Research Topics

Disease

5	Inflammation (Inflammations) 01/2022 - 04/2009
5	Neoplasms (Cancer) 04/2019 - 06/2006
3	Stroke (Strokes) 02/2024 - 01/2013
3	Sepsis (Septicemia) 01/2020 - 04/2009
3	Stomach Neoplasms (Stomach Cancer) 04/2019 - 06/2006
2	Dementia (Dementias) 02/2024 - 07/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2005
2	Cerebral Small Vessel Diseases 01/2022 - 12/2021
2	Lymphatic Metastasis 12/2013 - 04/2007
1	Teratoma (Teratoid Tumor) 05/2022
1	Fabry Disease (Fabry's Disease) 04/2022
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2022
1	Leukocytosis (Pleocytosis) 04/2022
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2022
1	Necrosis 01/2022
1	Atherosclerosis 01/2022
1	CADASIL 12/2021
1	Atrophy 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2020
1	Critical Illness (Critically Ill) 12/2020
1	COVID-19 12/2020
1	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 10/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Fever (Fevers) 01/2020
1	Adenocarcinoma 04/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Diabetes Mellitus 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Pelvic Neoplasms 01/2018
1	Azoospermia 09/2014
1	Nevi and Melanomas 12/2013
1	Nevus (Nevi) 12/2013
1	Neoplasm Metastasis (Metastasis) 12/2013
1	Melanoma (Melanoma, Malignant) 12/2013
1	Ischemic Stroke 01/2013
1	Acute Kidney Injury (Acute Renal Failure) 07/2011
1	Hypertension (High Blood Pressure) 07/2011
1	Renal Insufficiency (Renal Failure) 07/2011
1	Prostatic Neoplasms (Prostate Cancer) 03/2010
1	Multiple Organ Failure (MODS) 07/2009
1	Confusion (Bewilderment) 04/2009
1	Colorectal Neoplasms (Colorectal Cancer) 11/2007

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2022 - 04/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2019
2	Epidermal Growth Factor (EGF)IBA 02/2024 - 12/2021
2	AntigensIBA 01/2020 - 07/2009
2	SteroidsIBA 01/2020 - 07/2011
1	Amyloid (Amyloid Fibrils)IBA 07/2022
1	EnzymesIBA 04/2022
1	GalactosidasesIBA 04/2022
1	P-SelectinIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	E-SelectinIBA 01/2022
1	ChitinasesIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	CD40 Ligand (CD40L)IBA 01/2022
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2022
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2022
1	OsteopontinIBA 01/2022
1	ibrutinibIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	HomocysteineIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 12/2021
1	ApolipoproteinsIBA 01/2021
1	Amino Acids FDA Link 10/2020
1	Serine Proteases (Serine Protease)IBA 10/2020
1	Peptide Hydrolases (Proteases)FDA Link 10/2020
1	Serine (L-Serine)FDA Link 10/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	AntibodiesIBA 01/2020
1	Calcibiotic Root Canal SealerIBA 04/2019
1	human ERBB2 proteinIBA 04/2019
1	HydrogenIBA 01/2018
1	HDL CholesterolIBA 01/2018
1	LDL CholesterolIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	TubulinIBA 12/2016
1	Galectin 3 (LGALS3)IBA 12/2013
1	Galectin 1 (LGALS1)IBA 12/2013
1	3-n-butylphthalide (butylphthalide)IBA 01/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2011
1	Histones (Histone)IBA 03/2010
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2010
1	HLA-DR Antigens (HLA-DR)IBA 07/2009
1	ThymalfasinIBA 04/2009

Therapy/Procedure

4	Therapeutics 01/2022 - 02/2005
2	Drug Therapy (Chemotherapy) 05/2022 - 01/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 12/2020
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Immunotherapy 01/2020
1	Radiotherapy 01/2018
1	Herniorrhaphy 09/2014
1	Prostatectomy (Retropubic Prostatectomy) 03/2010
1	Subcutaneous Injections 04/2009
1	Immunomodulation 04/2009
1	Continuous Renal Replacement Therapy 04/2009